Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 0.61 | 2.28 | 1.46 | 0.72 |
Depreciation/ Depletion | 0.01 | 0.00 | 0.00 | 0.00 |
Non- Cash Items | 0.00 | 0.00 | 0.00 | 0.00 |
Changesin Working Capital | 4.70 | -6.64 | -27.89 | -0.68 |
Cashfrom Operating Activities | 5.32 | -4.35 | -26.43 | 0.03 |
Capital Expenditures | -0.01 | -0.01 | 0.00 | 0.00 |
Cashfrom Investing Activities | -0.01 | -0.01 | 0.00 | 0.00 |
Issuance( Retirement)of Debt Net | -5.34 | 1.42 | 8.16 | 0.00 |
Cashfrom Financing Activities | -5.34 | 1.42 | 29.49 | 0.00 |
Net Changein Cash | -0.03 | -2.94 | 3.06 | 0.03 |
Cash Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 |
Cash Taxes Paid | 0.16 | 0.67 | 0.37 | 0.00 |
Deferred Taxes | - | 0.00 | 0.00 | 0.00 |
Other Investing Cash Flow Items Total | - | 0.00 | 0.00 | 0.00 |
Financing Cash Flow Items | - | 0.00 | 0.00 | 0.00 |
Issuance( Retirement)of Stock Net | - | 0.00 | 21.33 | 0.00 |
EVOQ REMEDIES-MT Dividend EVOQ REMEDIES-MT Bonus EVOQ REMEDIES-MT News EVOQ REMEDIES-MT AGM EVOQ REMEDIES-MT Rights EVOQ REMEDIES-MT Splits EVOQ REMEDIES-MT Board Meetings EVOQ REMEDIES-MT Key Metrics EVOQ REMEDIES-MT Shareholdings EVOQ REMEDIES-MT Profit Loss EVOQ REMEDIES-MT Balance Sheet EVOQ REMEDIES-MT Q1 Results EVOQ REMEDIES-MT Q2 Results EVOQ REMEDIES-MT Q3 Results EVOQ REMEDIES-MT Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks